Braidwell as of Dec. 31, 2025
Portfolio Holdings for Braidwell
Braidwell holds 73 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Caris Life Sciences (CAI) | 6.7 | $211M | 7.8M | 26.98 | |
| Guardant Health Debt 1.250% 2/1 (Principal) | 6.2 | $192M | 105M | 1.83 | |
| Edgewise Therapeutics (EWTX) | 4.1 | $129M | 5.2M | 24.82 | |
| Repligen Corp Note 1.000%12/1 (Principal) | 3.5 | $111M | 101M | 1.10 | |
| Neurocrine Biosciences (NBIX) | 3.4 | $107M | 752k | 141.83 | |
| Glaukos (GKOS) | 3.3 | $104M | 922k | 112.91 | |
| Neogenomics Note 0.250% 1/1 (Principal) | 2.9 | $90M | 100M | 0.89 | |
| Nuvalent Inc-a (NUVL) | 2.6 | $83M | 821k | 100.59 | |
| Xenon Pharmaceuticals (XENE) | 2.6 | $82M | 1.8M | 44.82 | |
| Cg Oncology (CGON) | 2.5 | $78M | 1.9M | 41.52 | |
| Irhythm Technologies Note 1.500% 9/0 (Principal) | 2.3 | $73M | 52M | 1.40 | |
| Hinge Health Cl A (HNGE) | 1.9 | $61M | 1.3M | 46.45 | |
| Align Technology (ALGN) | 1.9 | $60M | 381k | 156.15 | |
| Kodiak Sciences (KOD) | 1.9 | $58M | 2.1M | 27.96 | |
| Soleno Therapeutics (SLNO) | 1.8 | $55M | 1.2M | 46.30 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.8 | $55M | 2.2M | 25.01 | |
| Neogenomics Com New (NEO) | 1.7 | $55M | 4.6M | 11.76 | |
| ACADIA Pharmaceuticals (ACAD) | 1.7 | $54M | 2.0M | 26.71 | |
| Spyre Therapeutics Com New (SYRE) | 1.7 | $54M | 1.6M | 32.76 | |
| Dianthus Therapeutics (DNTH) | 1.7 | $53M | 1.3M | 41.21 | |
| Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal) | 1.6 | $51M | 53M | 0.94 | |
| Celldex Therapeutics Com New (CLDX) | 1.6 | $51M | 1.9M | 27.16 | |
| Inspire Med Sys (INSP) | 1.6 | $50M | 541k | 92.23 | |
| Krystal Biotech (KRYS) | 1.6 | $50M | 202k | 246.54 | |
| Intuitive Surgical Com New (ISRG) | 1.5 | $47M | 83k | 566.36 | |
| Thermo Fisher Scientific (TMO) | 1.5 | $47M | 81k | 579.45 | |
| Brightspring Health Svcs (BTSG) | 1.4 | $45M | 1.2M | 37.45 | |
| CVS Caremark Corporation (CVS) | 1.4 | $45M | 564k | 79.36 | |
| Apogee Therapeutics (APGE) | 1.4 | $43M | 575k | 75.48 | |
| Nurix Therapeutics (NRIX) | 1.3 | $41M | 2.2M | 18.97 | |
| Vera Therapeutics Cl A (VERA) | 1.3 | $40M | 785k | 50.64 | |
| Irhythm Technologies (IRTC) | 1.2 | $39M | 217k | 177.44 | |
| Transmedics Group (TMDX) | 1.2 | $38M | 315k | 121.65 | |
| BioMarin Pharmaceutical (BMRN) | 1.1 | $36M | 602k | 59.43 | |
| Illumina (ILMN) | 1.1 | $35M | 270k | 131.16 | |
| Kymera Therapeutics (KYMR) | 1.1 | $35M | 454k | 77.81 | |
| Fulcrum Therapeutics (FULC) | 1.1 | $35M | 3.1M | 11.31 | |
| Penumbra (PEN) | 1.1 | $34M | 110k | 310.91 | |
| Mbx Biosciences (MBX) | 1.0 | $32M | 1.0M | 31.54 | |
| Rapt Therapeutics Com New (RAPT) | 1.0 | $32M | 930k | 33.87 | |
| Caredx (CDNA) | 1.0 | $30M | 1.6M | 18.84 | |
| Dyne Therapeutics (DYN) | 0.9 | $29M | 1.5M | 19.56 | |
| Engene Holdings (ENGN) | 0.9 | $28M | 3.1M | 9.03 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.9 | $28M | 1.3M | 21.74 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.9 | $27M | 8.4M | 3.25 | |
| Danaher Corporation (DHR) | 0.9 | $27M | 118k | 228.92 | |
| Argenx Se Sponsored Adr (ARGX) | 0.8 | $26M | 31k | 840.95 | |
| Natera (NTRA) | 0.8 | $26M | 112k | 229.09 | |
| Bright Minds Biosciences Com New (DRUG) | 0.8 | $25M | 324k | 78.04 | |
| Terns Pharmaceuticals (TERN) | 0.7 | $23M | 575k | 40.40 | |
| Evolus (EOLS) | 0.7 | $21M | 3.1M | 6.65 | |
| Biogen Idec (BIIB) | 0.7 | $20M | 116k | 175.99 | |
| Orthopediatrics Corp. (KIDS) | 0.6 | $20M | 1.1M | 17.76 | |
| Tectonic Therapeutic (TECX) | 0.6 | $19M | 928k | 20.86 | |
| Ventyx Biosciences (VTYX) | 0.6 | $17M | 1.9M | 9.03 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.5 | $17M | 3.2M | 5.24 | |
| Compass Therapeutics (CMPX) | 0.5 | $15M | 2.8M | 5.37 | |
| Monte Rosa Therapeutics (GLUE) | 0.5 | $15M | 948k | 15.68 | |
| Harrow Health (HROW) | 0.5 | $15M | 295k | 49.00 | |
| X4 Pharmaceuticals Com New (XFOR) | 0.4 | $14M | 3.4M | 4.00 | |
| Repligen Corporation (RGEN) | 0.4 | $13M | 82k | 163.86 | |
| Icon SHS (ICLR) | 0.4 | $13M | 73k | 182.22 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.4 | $13M | 314k | 41.25 | |
| Grail (GRAL) | 0.4 | $12M | 143k | 85.59 | |
| Surrozen Com New (SRZN) | 0.3 | $11M | 470k | 22.60 | |
| Relmada Therapeutics (RLMD) | 0.2 | $7.6M | 1.6M | 4.83 | |
| Xencor (XNCR) | 0.2 | $7.0M | 459k | 15.31 | |
| Castle Biosciences (CSTL) | 0.2 | $6.9M | 177k | 38.90 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.2 | $5.1M | 312k | 16.24 | |
| Billiontoone Cl A (BLLN) | 0.1 | $4.1M | 50k | 81.84 | |
| Oruka Therapeutics (ORKA) | 0.1 | $2.6M | 85k | 30.31 | |
| Karyopharm Therapeutics Com New (KPTI) | 0.1 | $2.2M | 303k | 7.36 | |
| Pulmonx Corp (LUNG) | 0.1 | $1.7M | 753k | 2.21 |